Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Achyut Healthcare's board, meeting on January 21, 2026, approved its unaudited Q3 FY26 results showing revenue from operations of Rs. 156.96 lakhs (down sharply from Rs. 254.65 lakhs in Q2 FY26), with 9-month revenue at Rs. 720.83 lakhs versus Rs. 212.66 lakhs in the prior year. Net profit for Q3 was just Rs. 0.43 lakhs versus Rs. 12.10 lakhs in the previous quarter, while 9-month net profit stood at Rs. 23.73 lakhs (down from Rs. 38.59 lakhs a year ago). The board approved shifting its registered office within Ahmedabad, increasing authorised capital from Rs. 24 crore to Rs. 26 crore, and a preferential issue of up to 58 lakh equity shares at Rs. 6 each (Rs. 5 premium), raising up to Rs. 3.48 crore from promoter and non-promoter allottees. The company also recently migrated from the BSE SME platform to the BSE Mainboard effective January 2, 2026. An EGM has been scheduled for February 19, 2026 to seek shareholder approvals.
Q3 results show a steep sequential drop in both revenue and profits, which may pressure the stock, though the 9-month picture is still better year-on-year. The small Rs. 3.48 crore preferential issue with promoter participation signals insider confidence, and the BSE mainboard migration should improve liquidity and visibility for retail investors.